This weekend, thousands of riders will take to the streets for Pelotonia — the annual bike ride that raises millions of dollars for cancer research right here in Columbus.
One of the projects supported by that funding is showing real promise: a new drug discovered by Ohio State University researchers that’s being developed to treat some of the most difficult-to-target cancers.
Chad Bennett is executive director of chemistry at the Drug Development Institute at Ohio State. Bennett co-led the team that developed the new drug…